| Record ID | marc_loc_2016/BooksAll.2016.part34.utf8:145540815:1576 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part34.utf8:145540815:1576?format=raw |
LEADER: 01576cam a22004214a 4500
001 2007035586
003 DLC
005 20141212081024.0
008 070828s2008 ne af b 001 0 eng
010 $a 2007035586
016 7 $a101315286$2DNLM
020 $a9780123695208 (alk. paper)
020 $a0123695201 (alk. paper)
035 $a(OCoLC)ocn169452881
035 $a(OCoLC)169452881
040 $aDNLM/DLC$cDLC$dNLM$dBAKER$dBTCTA$dYDXCP$dC#P$dBWX$dDLC
042 $apcc
050 00 $aRS420$b.K47 2008
060 10 $aQV 744$bK395d 2008
082 00 $a615/.19$222
100 1 $aKerns, Edward Harvel.
245 10 $aDrug-like properties :$bconcepts, structure design and methods : from ADME to toxicity optimization /$cEdward H. Kerns and Li Di.
260 $aAmsterdam ;$aBoston :$bAcademic Press,$cc2008.
300 $axix, 526 p., [2] p. of plates :$bill. (some col.) ;$c27 cm.
504 $aIncludes bibliographical references (p. 492) and index.
650 0 $aPharmaceutical chemistry.
650 0 $aDrugs$xStructure-activity relationships.
650 0 $aDrug development.
650 0 $aDrugs$xDesign.
650 12 $aDrug Design.
650 22 $aDrug Evaluation, Preclinical.
650 22 $aDrug Toxicity.
650 22 $aPharmaceutical Preparations$xmetabolism.
650 22 $aPharmacokinetics.
650 22 $aStructure-Activity Relationship.
700 1 $aDi, Li.
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/toc/ecip0726/2007035586.html
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0811/2007035586-d.html